XTL Biopharmaceutica Fundamental Relationships

XTLB -- Israel Stock  

ILS 8.30  2.60  23.85%

The Drivers Module shows relationships between XTL Biopharmaceutica's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of XTL Biopharmaceuticals Ltd over time as well as its relative position and ranking within its peers. See also Your Current Watchlist

XTL Biopharmaceuticals Shares Outstanding vs. Gross Profit Fundamental Analysis

XTL Biopharmaceuticals Ltd is rated below average in gross profit category among related companies. It is rated below average in shares outstanding category among related companies .
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
XTL Biopharmaceutica 
Gross Profit 
 = 
Revenue 
-  
Cost of Revenue 
=
(5 K)
Gross Profit varies significantly from one sector to another and tells investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted bases which include exotic instruments such as options, or convertibles bonds.
XTL Biopharmaceutica 
Shares Outstanding 
 = 
Public Shares 
Repurchased 
=
514.21 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

XTL Biopharmaceuticals Shares Outstanding Comparison

  Shares Outstanding 
      XTL Biopharmaceutica Comparables 
XTL Biopharmaceutica is currently under evaluation in shares outstanding category among related companies.
  Revenue 
      XTL Biopharmaceutica Comparables 
XTL Biopharmaceutica is currently under evaluation in revenue category among related companies.
Search macroaxis.com